The Federal Reserve made no changes to its median interest-rate projections, with a quarter-point reduction still penciled in for next year, according to the Summary of Economic Projections published ...

The forecasts will offer a glimpse of the path for policy at a highly uncertain moment for economy — and the central bank. By Colby Smith Federal Reserve officials are scheduled to release a fresh set ...

The path to glory at the 2026 World Cup has now been laid out after the contenders discovered their tournament fate at Friday's draw ceremony in Washington which was dominated by Donald Trump. Story ...

Pour one out for the ancient MetroCard and its equally old cousin, the PATH SmartLink card. The beginning of the end for these longtime ways to pay fares on the bi-state PATH system came Thursday when ...

Nonprofit Keshet has been a leading advocate for Jewish LGBTQ+ rights for nearly three decades. This year, however, longtime CEO Idit Klein stepped down, while at about the same time, the Trump ...

Japan’s state-backed chip venture Rapidus Corp. aims to go public around fiscal 2031 in a bid to bolster the country’s domestic chipmaking capabilities. The government plans to invest around ¥100 ...

Senate Majority Leader John Thune says he believes the legislative effort should begin in the House. Lawmakers are quietly discussing how to quickly move new Russia sanctions legislation — this time ...

The cost of a single PATH train ticket is set to increase next spring — and will climb steadily each year until it hits $4 by 2029, Port Authority officials said. A single trip on the PATH train, ...

They live in New Jersey, Michigan and Washington state — six young men arrested in recent weeks and charged in an alleged ISIS-inspired terror plot. The suspects ...

Background: Alzheimer’s disease (AD) is the most prevalent cause of dementia in the elderly, imposing a significant societal burden. Current therapeutic approaches primarily address symptoms, ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...